US Alzheimer’s drug pioneer Anavex presses-on, despite regulatory setback
Alzheimer’s drug pioneer Anavex is pressing ahead with plans to [...]
Agetech investment round-up featuring Life Biosciences, Eli Lilly, L-Nutra & LinkGevity
Agetech investment round-up featuring Life Biosciences, Eli Lilly, L-Nutra & [...]
Agetech research roundup – featuring Dr David Sinclair and Shinya Yamanaka
Leading healthy-ageing scientist Dr David Sinclair is using AI to [...]
Agetech world investment, research and technology round-up
MINNESOTA-based Medtronic has agreed to acquire neurovascular technology company Scientia [...]
The Agetech World research roundup
Super-ageing key, Seaweed’s special, hair-raising breakthrough and more The secret [...]
Agetech investment and innovation round-up
Global market to hit US$740bn in 2026, longevity needs lifts? [...]
Interview: The US company appealing Europe’s rejection of daily Alzheimer’s pill
Despite having its application for a new, daily Alzheimer’s pill [...]
Agetech World innovation & investment round-up
Regenerative innovator's cash boost, are biological clocks out of time?, [...]
Agetech investment & innovation round-up
Long-term gut health and female finance, London likes longevity New [...]
Interview: Dr Matthew Bennett on building resilience and a pain-free healthspan
Harnessing the multi-dimensional capabilities of the human body is key [...]
